NO971508D0 - Analoger sv sur fibroblastvekstfaktor med forökt stabilitet og biologisk aktivitet - Google Patents

Analoger sv sur fibroblastvekstfaktor med forökt stabilitet og biologisk aktivitet

Info

Publication number
NO971508D0
NO971508D0 NO971508A NO971508A NO971508D0 NO 971508 D0 NO971508 D0 NO 971508D0 NO 971508 A NO971508 A NO 971508A NO 971508 A NO971508 A NO 971508A NO 971508 D0 NO971508 D0 NO 971508D0
Authority
NO
Norway
Prior art keywords
growth factor
biological activity
fibroblast growth
increased stability
acidic fibroblast
Prior art date
Application number
NO971508A
Other languages
English (en)
Other versions
NO971508L (no
Inventor
Tsutomu Arakawa
Gary Michael Fox
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of NO971508D0 publication Critical patent/NO971508D0/no
Publication of NO971508L publication Critical patent/NO971508L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factor [FGF]
    • C07K14/501—Fibroblast growth factor [FGF] acidic FGF [aFGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO971508A 1994-10-13 1997-04-03 Analoger av sur fibroblastvekstfaktor med forökt stabilitet og biologisk aktivitet NO971508L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32347394A 1994-10-13 1994-10-13
PCT/US1995/012907 WO1996022369A1 (en) 1994-10-13 1995-10-12 Analogs of acidic fibroblast growth factor having enhanced stability and biological activity

Publications (2)

Publication Number Publication Date
NO971508D0 true NO971508D0 (no) 1997-04-03
NO971508L NO971508L (no) 1997-06-13

Family

ID=23259345

Family Applications (1)

Application Number Title Priority Date Filing Date
NO971508A NO971508L (no) 1994-10-13 1997-04-03 Analoger av sur fibroblastvekstfaktor med forökt stabilitet og biologisk aktivitet

Country Status (10)

Country Link
EP (1) EP0786000A1 (no)
JP (1) JPH10507929A (no)
CN (1) CN1169158A (no)
AU (1) AU3828195A (no)
CA (1) CA2201944C (no)
CZ (1) CZ98097A3 (no)
HU (1) HUT77746A (no)
NO (1) NO971508L (no)
SK (1) SK43297A3 (no)
WO (1) WO1996022369A1 (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ98297A3 (cs) * 1994-10-13 1998-08-12 Amgen Inc. Způsob purifikace keratinocytových růstových faktorů
US7232667B2 (en) 1995-02-14 2007-06-19 Human Genome Sciences, Inc. Keratinocyte growth factor-2 polynucleotides
US6693077B1 (en) 1995-02-14 2004-02-17 Human Genome Sciences, Inc. Keratinocyte growth factor-2
US6077692A (en) 1995-02-14 2000-06-20 Human Genome Sciences, Inc. Keratinocyte growth factor-2
US6743422B1 (en) 1996-10-15 2004-06-01 Amgen, Inc. Keratinocyte growth factor-2 products
WO1998039436A2 (en) * 1997-03-03 1998-09-11 Eisai Co., Ltd. Fibroblast growth factor mutein compositions and methods of use therefor
US6869927B1 (en) 1997-12-22 2005-03-22 Human Genome Sciences, Inc. Keratinocyte growth factor-2 formulations
EP1041996A4 (en) 1997-12-22 2003-05-14 Human Genome Sciences Inc KERATINOCYTE GROWTH FACTOR-2 FORMULATIONS
US6274712B1 (en) 1997-12-23 2001-08-14 3-Dimensional Pharmaceuticals, Inc. Analogs of human basic fibroblast growth factor mutated at one or more of the positions glutamute 89, aspartate 101 or leucine 137
IL139380A0 (en) * 2000-10-31 2001-11-25 Prochon Biotech Ltd Active variants of fibroblast growth factor
TWI634898B (zh) * 2013-10-07 2018-09-11 雅祥生技醫藥股份有限公司 經修飾之人類酸性纖維母細胞生長因子及其組合物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2098484A1 (en) * 1990-12-18 1992-06-19 Tsutomu Arakawa Analogs of acidic fibroblast growth factor having enhanced stability and biological activity

Also Published As

Publication number Publication date
HUT77746A (hu) 1998-07-28
MX9702475A (es) 1997-07-31
WO1996022369A1 (en) 1996-07-25
EP0786000A1 (en) 1997-07-30
NO971508L (no) 1997-06-13
AU3828195A (en) 1996-08-07
CZ98097A3 (en) 1997-12-17
JPH10507929A (ja) 1998-08-04
CN1169158A (zh) 1997-12-31
CA2201944C (en) 2002-12-31
CA2201944A1 (en) 1996-07-25
SK43297A3 (en) 1998-01-14

Similar Documents

Publication Publication Date Title
EE9700209A (et) Dihüdropürimidiinid ja nende kasutamine
FI952931A0 (fi) Insuliinianalogiformulaatioita
DE68921469D1 (de) Peptidderivate und deren verwendung.
NO970088D0 (no) Acylazolonderivater med anti-Helicobacteraktivitet
NO952039D0 (no) Proteiner med glykosyltransferase-aktivitet
IT1283637B1 (it) Composti ad attivita' antinfiammatoria ed immunosoppressiva
NO970087D0 (no) Urea- og tiourea-azolonderivater med anti-Helicobacteraktivitet
DE69223266T2 (de) Peptidderivate und deren Verwendung
DE69821629D1 (de) Kombinationen von cytokine mit neurotropen aktivität
IL135374A0 (en) Fibroblast growth factor with hepatocyte proliferation activity
DE69314280D1 (de) Rekombinantes Nitrilase und deren Verwendung
DK0721457T3 (da) 2',5'-Oligoadenylat-2',3'-cyclophosphater og 2',5'-oligo-adenylater med antipapillomavirusaktivitet
NO971508D0 (no) Analoger sv sur fibroblastvekstfaktor med forökt stabilitet og biologisk aktivitet
NO992103L (no) Dihydropyroner med forbedret antiviral aktivitet
IT1282692B1 (it) Citochine modificate per l'uso in terapia
EP0575339A4 (en) ANALOGS OF THE AZID FIBROBLASTS GROWTH FACTOR WITH INCREASED STABILITY AND BIOLOGICAL ACTIVITY.
DE69304538D1 (de) Aminosäure-derivate und deren verwendung
ATE305455T1 (de) 1,3-dihydro-2h-imidazol-2-on-derivate mit pdeiv und cytokin inhibierender aktivität
DE69009204D1 (de) Hydroxyperoxide und ihre Verwendung.
DE59107525D1 (de) Peptidamidase und deren Verwendung
TR25733A (tr) Fungusid aktivitesine sahip bilesik kombinasyonlari
DE69508700D1 (de) Aminosäurederivat mit Anti-CCK-Aktivität
DE69942722D1 (de) Mikrobenkultur mit erhöhter glutaminase-aktivität und ihre verwendung
DE69121210D1 (de) Therapeutische verwendung des fibroblastenwachstumsfaktors
FI925468A (fi) Kinolylmetoxifenylaettiksyraacylamider och -ureor